EUVIMEDEUVIMED entdecken
Crossref

Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500

Khandoker Asiqur Rahaman, Md Sofequl Islam Mukim, Md Lemon Hasan, Soon Jin Choi, Soyeon Park, Hyeok Kim, Yuna Jung, Cheol-Ho Pan, Sung-Hwan Moon, Hophil Min, Oh-Seung Kwon, Shihab Uddin und 4 weitere

Biomaterials Research · 01.01.2026 · 30

DOI: 10.34133/bmr.0418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 30.09.2026. Verfasst von Khandoker Asiqur Rahaman und 15 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Korea Institute of Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The therapeutic application of peptides has expanded considerably in clinical and regenerative medicine; however, the contribution of peptide metabolites to therapeutic efficacy remains poorly understood. We previously identified N -acetyl- l -leucyl- l -lysine (Ac-LK) as the major metabolite of TB-500 by metabolic profiling and hypothesized that it contributes to the biological activity of the parent peptide. Initial screening demonstrated that Ac-LK exhibited greater SARS-CoV-2 main protease inhibitory activity than TB-500, the other identified metabolites, and the constituent amino acids. We therefore systematically characterized Ac-LK using cellular uptake, endothelial cell functional assays, proteomic profiling, and in vivo wound healing. Under the experimental conditions employed, Ac-LK exhibited enhanced protection against hypoxia/reoxygenation-induced injury, stronger promigratory and barrier-stabilizing activities, broader regulation of pathways related to cytoskeletal organization, cadherin-mediated adhesion, and protein translation, and accelerated wound healing. Collectively, these findings identify Ac-LK as a biologically active metabolite of TB-500 and support the hypothesis that metabolic conversion contributes to the therapeutic actions of the parent peptide.

Förderung

  • Korea Institute of Science and Technology

Zitieren

APA

Rahaman, K. A., Mukim, M. S. I., Hasan, M. L., Choi, S. J., Park, S., Kim, H., Jung, Y., Pan, C., Moon, S., Min, H., Kwon, O., Uddin, S., Jeon, H., Joung, Y. K., Song, D., & Ha, H. (2026). Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0418

Vancouver

Rahaman KA, Mukim MSI, Hasan ML, Choi SJ, Park S, Kim H, et al. Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500. Biomaterials Research. 2026;30. doi:10.34133/bmr.0418

BibTeX
@article{Rahaman2026,
  author = {Rahaman, Khandoker Asiqur and Mukim, Md Sofequl Islam and Hasan, Md Lemon and Choi, Soon Jin and Park, Soyeon and Kim, Hyeok and Jung, Yuna and Pan, Cheol-Ho and Moon, Sung-Hwan and Min, Hophil and Kwon, Oh-Seung and Uddin, Shihab and Jeon, Hojeong and Joung, Yoon Ki and Song, Dae-Geun and Ha, Hyung-Seop},
  title = {Functional Characterization of N -acetyl- l -Leucyl- l -Lysine Supports a Peptide Prodrug Mechanism for TB-500},
  journal = {Biomaterials Research},
  year = {2026},
  volume = {30},
  doi = {10.34133/bmr.0418}
}
Kostenlos starten →